Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer
Clinical trial NCT03414684 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03414684
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-30
- Primary completion
- 2021-09-28
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.